North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, and Growth Outlook (2026–2034)
North America dominates the market due to well-established healthcare infrastructure, strong reimbursement policies, and a high incidence of brain aneurysms. The presence of leading pharmaceutical companies and continuous research initiatives also contribute to the region’s leading position. Increasing adoption of advanced neuroprotective drugs and calcium channel blockers is enhancing treatment outcomes, which in turn fuels … Read more